US2013336941A1PendingUtilityA1
Long lasting absorption of flavonoids
Est. expiryAug 24, 2026(~0.1 yrs left)· nominal 20-yr term from priority
A61P 9/00A61P 1/00A61P 17/00A61P 19/08A61K 38/47A23L 33/18A61K 8/11A61K 2800/412A61K 8/602C12Y 302/01006A61Q 19/00A61K 31/7048C12N 9/2402A61K 8/66C12Y 302/0104C12R 2001/25C12R 2001/46C12R 2001/225C12N 1/205A23L 1/3053
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods for a ong-term and sustained release of flavonoids, in particular rhamnose-containing flavonoids, and for prolonging the uptake of said flavonoids in the gastro-intestinal tract. It further relates to compositions comprising said flavonoid and α-rhamnosidase. It also encompasses compositions comprising hesperidin and hesperetin-7-gluoside.
Claims
exact text as granted — not AI-modifiedThe invention is claimed as follows:
1 : A product comprising:
a first composition comprising a rhamnose-containing flavonoid; and a second composition comprising an α-rhamnosidase, and the first and second compositions do not react with each other unless certain conditions are met.
2 : The product according to claim 1 , wherein the certain conditions are selected from the group consisting of pH, temperature, water activity and combinations thereof.
3 : The product according to claim 1 , wherein the certain conditions are gastro-intestinal tract conditions.
4 : The product according to claim 1 , wherein the α-rhamnosidase is only able to cleave the rhamnose-containing flavonoid in gastro-intestinal tract conditions.
5 : The product according to claim 4 , wherein the α-rhamnosidase is only able to cleave the rhamnose-containing flavonoid at a temperature provided by the gastro-intestinal tract conditions.
6 : The product according to claim 1 , wherein the product has a pH that prevents the α-rhamnosidase from cleaving the rhamnose-containing flavonoid.
7 : The product according to claim 1 , wherein the α-rhamnosidase has been treated with an inhibitor such that only when gastro-intestinal tract conditions are met is the α-rhamnosidase able to cleave the rhamnose-containing flavonoid.
8 : The product according to claim 1 , wherein the α-rhamnosidase is encapsulated in a micro-organism capable of producing α-rhamnosidase, and the product has conditions in which the micro-organism has a metabolic rate such that the α-rhamnosidase is not released by the micro-organism.
9 : The product according to claim 8 , wherein the product has a water activity that lowers the metabolic rate of the micro-organism to prevent the micro-organism from releasing the α-rhamnosidase.
10 : The product according to claim 9 , wherein the micro-organism is a bacterium.
11 : The product according to claim 10 , wherein the bacterium is selected from Lactobacillus, Bifidobacterium, Streptococcus, Lactococcus, Enterococcus, Bacillus, Staphylococcus, Leuconostoc, Pediococcus, Oenococcus and combinations thereof.
12 : The product according to claim 10 , wherein the bacterium is selected from the group consisting of Lactobacillus crispatus ATCC33820 , Lactobacillus crispatus CNCM I-3654 , Lactobacillus plantarum ATCC8014 , Lactobacillus plantarum CNCM I-3653 , Lactobacillus gasseri CNCM I-3795 and mixtures thereof.
13 : The product according to claim 8 , wherein the micro-organism is present in an amount of 10 6 -10 10 cfu/g.
14 : The product according to claim 1 , wherein the second composition is a powder.
15 : The product according to claim 1 , wherein the rhamnose-containing flavonoid is hesperidin.
16 : The product according to claim 1 , wherein the product is a composition selected from the group consisting of nutritional composition, a pharmaceutical composition and a cosmetic composition.
17 : The product according to claim 1 , wherein the product is selected from the group consisting of a liquid, a solution, a spray, a powder, a tablet, a capsule, a yoghurt, a biscuit, milk, a beverage, chocolate, ice cream, breakfast cereal flakes, a breakfast cereal bar, a milk powder, a soy-based product, a non-milk fermented product, a nutritional supplement, a food supplement, a pet food, an infant formula and combinations thereof.
18 : A product comprising:
a first powder comprising a rhamnose-containing flavonoid; and a second powder comprising an α-rhamnosidase, and the first and second powders do not react with each other unless certain conditions are met.
19 : A method of improving aesthetics or comfort of skin, a coat, or hair of humans or pets, the method comprising the step of orally administering to a human or a pet in need of same a product comprising a first composition comprising a rhamnose-containing flavonoid and a second composition comprising an α-rhamnosidase, and the α-rhamnosidase is only able to cleave the rhamnose-containing flavonoid in gastro-intestinal tract conditions.
20 : A method of treating damage to the skin, coat and/or hair of humans or pets, the method comprising the step of orally administering to a human or a pet in need of same a product comprising a first composition comprising a rhamnose-containing flavonoid and a second composition comprising an α-rhamnosidase, and the α-rhamnosidase is only able to cleave the rhamnose-containing flavonoid in gastro-intestinal tract conditions.
21 : A method for improving skin health, the method comprising the step of administering separately and simultaneously a first composition comprising at least one rhamnose-containing flavonoid and a second composition comprising α-rhamnosidase.
22 : A composition comprising a mix of hesperidin and hesperetin-7-glucoside.
23 : The composition according to claim 22 , wherein the hesperidin and hesperetin-7-glucoside are present in the composition in a ratio of between 70/30 to 50/50.Join the waitlist — get patent alerts
Track US2013336941A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.